A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

GLP-1 medications come with side effects, including the fact that you need to give yourself a weekly injection in the abdomen. GI side effects are most common and include nausea, vomiting and ...

Eli Lilly’s shares shot up 11% pre-market on Thursday after orforglipron became the first small-molecule GLP-1 drug to ace a ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

However, 1 in 10 patients using GLP-1 receptor agonists experiences gastrointestinal side effects, which are usually not serious but can lead to more serious complications. How do GLP-1 receptor ...

Other GLP-1 receptor agonists like Ozempic have been shown to cause side effects twice as much in women as in men. In one study, women were more likely to report dizziness, headaches, and vomiting ...

Some evidence suggests that females may be more likely to have side effects from GLP-1 receptor agonists, but this hasn’t been specifically shown with Ozempic. Ozempic may also be prescribed off ...